Hemab Therapeutics Holdings Inc.
Organization details
- Legal name
- Hemab Therapeutics Holdings Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- COAG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002114044
- EIN
- 41-4241952
Board of directors
-
Akshay Vaishnaw · DirectorSince 2026
-
Benny Sorensen · Director · See RemarksSince 2026
- Since 2026
-
Keli Walbert · DirectorSince 2026
-
Laura Tadvalkar · DirectorSince 2026
-
Linda Bain · DirectorSince 2026
- Since 2026
- Since 2026
Board connections
6 of this board's directors also sit on 37 other boards. 37 are in the same sector.
-
ARS Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acrivon Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acumen Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Artiva Biotherapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bambusa Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bicara Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Black Diamond Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Climb Bio Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Evommune Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Freenome Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Jade Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Janux Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
LENZ Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Mineralys Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Nkarta Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Parabilis Medicines Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
PepGen Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Septerna Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Sionna Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Solid Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
SpyGlass Pharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Tyra Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Vor Biopharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Wave Life Sciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Werewolf Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Agios Pharmaceuticals Inc. Same sectorvia John Maraganore
-
Arvinas Inc. Same sectorvia Linda Bain
- via Linda Bain
-
Beam Therapeutics Inc. Same sectorvia John Maraganore
-
City Therapeutics Inc. Same sectorvia John Maraganore
-
Editas Medicine Inc. Same sectorvia Akshay Vaishnaw
-
Kymera Therapeutics Inc. Same sectorvia John Maraganore
-
ProKidney Corp. Same sectorvia John Maraganore
-
Rapport Therapeutics Inc. Same sectorvia John Maraganore
-
Scholar Rock Holding Corporation Same sectorvia Akshay Vaishnaw
-
Spruce Biosciences Inc. Same sectorvia Keli Walbert
-
Takeda Pharmaceutical Company Limited Same sectorvia John Maraganore
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $55,460,171
- 16 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Open-market purchase | +61,523 | $24.98 | $1,536,845 |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Open-market purchase | +6,146 | $24.89 | $152,974 |
| May 20, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Open-market purchase | +996 | $24.94 | $24,840 |
| May 19, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Open-market purchase | +3,802 | $24.97 | $94,936 |
| May 12, 2026 | Peter Kolchinsky 10% owner | Open-market purchase | +6,387 | $24.90 | $159,036 |
| May 11, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +14,149 | $24.47 | $346,226 |
| May 11, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +25,720 | $25.00 | $643,000 |
| May 8, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +1,483 | $24.98 | $37,045 |
| May 7, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +7,921 | $24.34 | $192,797 |
| May 7, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +1,985 | $24.95 | $49,526 |
| May 6, 2026 | Rajeev M. Shah Director, 10% owner | Open-market purchase | +14,611 | $23.77 | $347,303 |
| May 6, 2026 | Rajeev M. Shah Director, 10% owner | Open-market purchase | +53,407 | $24.83 | $1,326,096 |
| May 5, 2026 | Rajeev M. Shah Director, 10% owner | Open-market purchase | +87,143 | $24.59 | $2,142,846 |
| May 5, 2026 | Rajeev M. Shah Director, 10% owner | Open-market purchase | +10,268 | $25.00 | $256,700 |
| May 4, 2026 | Rajeev M. Shah Director, 10% owner | Derivative conversion | +3,607,846 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Hemab Therapeutics Holdings Inc.
How many directors are on Hemab Therapeutics Holdings Inc.'s board?
Hemab Therapeutics Holdings Inc.'s board has 8 directors: Akshay Vaishnaw, Benny Sorensen, John Maraganore, Keli Walbert, Laura Tadvalkar, Linda Bain, Peter Kolchinsky and Rajeev M. Shah.
Are Hemab Therapeutics Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Hemab Therapeutics Holdings Inc. insiders bought $55.5 million of shares in 16 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="hemab-therapeutics-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.